Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178911 | SCV000231091 | benign | not specified | 2014-10-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000658609 | SCV000780387 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | TCIRG1: BS2 |
Labcorp Genetics |
RCV000658609 | SCV001027329 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001114992 | SCV001272923 | benign | Autosomal recessive osteopetrosis 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000178911 | SCV002103802 | benign | not specified | 2022-02-18 | criteria provided, single submitter | clinical testing | Variant summary: TCIRG1 c.479G>A (p.Gly160Glu) results in a non-conservative amino acid change in the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.005 in 155404 control chromosomes in the gnomAD database, including 3 homozygotes. The observed variant frequency is approximately 3.0 fold of the estimated maximal expected allele frequency for a pathogenic variant in TCIRG1 causing Osteopetrosis phenotype (0.0016), strongly suggesting that the variant is benign. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Breakthrough Genomics, |
RCV000658609 | SCV005216247 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001114992 | SCV002094900 | likely benign | Autosomal recessive osteopetrosis 1 | 2019-11-13 | no assertion criteria provided | clinical testing |